Copyright
©The Author(s) 2021.
World J Gastroenterol. May 14, 2021; 27(18): 2219-2237
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2219
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2219
Time | Placebo | Active treated | ||||
Females | Males | P value | Females | Males | P value | |
0 | 31 ± 5 | 29 ± 4 | 0.3 | 32 ± 5 | 30 ± 5 | 0.09 |
2 wk | 31 ± 6 | 29 ± 6 | 0.2 | 28 ± 6 | 28 ± 5 | 0.5 |
1 mo | 31 ± 6 | 27 ± 7 | 0.1 | 27 ± 7 | 29 ± 5 | 0.5 |
3 mo | 30 ± 4 | 26 ± 4 | 0.01 | 29 ± 6 | 27 ± 5 | 0.7 |
- Citation: El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World J Gastroenterol 2021; 27(18): 2219-2237
- URL: https://www.wjgnet.com/1007-9327/full/v27/i18/2219.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i18.2219